Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease
Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children – updated analysis of randomised controlled trials
Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer
Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis – a double-blind, double-dummy study
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women
The impact of abdominal computed tomography in a tertiary referral centre emergency department on the management of patients with inflammatory bowel disease
Genetic risk factors for Clostridium difficile infection in ulcerative colitis
Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse
The incidence of acute pancreatitis: impact of social deprivation, alcohol consumption, seasonal and demographic factors
Commentary: coeliac disease and atherosclerosis – hand in hand?
Commentary: coeliac disease and atherosclerosis – hand in hand? Authors' reply
Commentary: is Faecalibacterium prausnitzii a potential treatment for maintaining remission in ulcerative colitis?
Commentary: antibodies reacting with the infliximab Fab portion – something new?
Commentary: antibodies reacting with the infliximab Fab portion – something new? Authors' reply
Commentary: absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C
Commentary: absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C – authors' reply
Commentary: predicting complicated Crohn's disease and surgery – phenotypes, genetics, serology and psychological characteristics of a population-based cohort
Commentary: predicting complicated Crohn's disease and surgery – phenotypes, genetics, serology and psychological characteristics of a population-based cohort – authors' reply
Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon-a2a/ribavirin in combination with a direct-acting anti-viral
Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon-a2a/ribavirin in combination with a direct-acting anti-viral – authors' reply
Letter: atherosclerosis and coeliac disease – another feature of the changing paradigm?
Letter: atherosclerosis and coeliac disease – another feature of the changing paradigm? Authors' reply
Letter: the role of sub-clinical inflammation and TRPV1 in the development of IBS-like symptoms in ulcerative colitis in remission
Letter: antibiotic dose adjustment in patients with advanced liver disease
Letter: antibiotic dose adjustment in patients with advanced liver disease – authors' reply